Deregulation of STING Signaling in Colorectal Carcinoma Constrains DNA Damage Responses and Correlates With Tumorigenesis

Xia, Tianli, Konno, Hiroyasu, Ahn, Jeonghyun, Barber, Glen N.·2016·Cell Reports

Cited by (590)

Items 301–400 of 590

  1. The Multiple Potential Biomarkers for Predicting Immunotherapy Response—Finding the Needle in the Haystack
    Tamiem Adam, Therese M. Becker, Wei Ming Chua, Victoria Bray, Tara Laurine Roberts · 2021 · Cancers
  2. BCG invokes superior STING ‐mediated innate immune response over radiotherapy in a carcinogen murine model of urothelial cancer
    Kara A. Lombardo, Aleksandar Obradović, Alok Kumar Singh, James L. Liu, Gregory A. Joice, Max R. Kates, William R. Bishai, David James McConkey, Alcides Chaux, Marie‐Lisa Eich et al. · 2021 · The Journal of Pathology
  3. Oncolytic viruses: A new immunotherapeutic approach for breast cancer treatment?
    Juan Miguel Cejalvo, Claudette Falato, Lorea Villanueva, Pablo Tolosa, Xavier González, Mariona Pascal, Jordi Canes, Joaquín Gavilá, Luís Manso, Tomás Pascual et al. · 2022 · Cancer Treatment Reviews
  4. On taking the STING out of immune activation
    Andra Banete, Kyle Seaver, Devyani Bakshi, Katrina Gee, Sameh Basta · 2018 · Journal of Leukocyte Biology
  5. cGAS: action in the nucleus
    Yikai Lu, Mengmeng Zhao, Li Chen, Yan Wang, Tianhao Liu, Haipeng Liu · 2024 · Frontiers in Immunology
  6. Chromosome instability and aneuploidy as context-dependent activators or inhibitors of antitumor immunity
    Xiaohong Kuang, Jian Li · 2022 · Frontiers in Immunology
  7. STING promotes proliferation and induces drug resistance in colorectal cancer by regulating the AMPK-mTOR pathway
    Huihui Yao, Suo Wang, Xin Zhou, Jinbing Sun, Guoqiang Zhou, Diyuan Zhou, Guoliang Chen, Xinyu Shi, Junjie Chen, Bo Shi et al. · 2022 · Journal of Gastrointestinal Oncology
  8. Brief report: STING expressed in tumor and non-tumor compartments has distinct roles in regulating anti-tumor immunity
    Kim, Jennie C., Liu, Xian, Fitzgerald, Karen, Eng, Jason S., Orf, Jessica, O’Brien, Sarah A., Belmontes, Brian, Casbon, Amy-Jo, Novitskiy, Sergey V., Tarbell, Kristin V. et al. · 2023 · Cancer Immunology, Immunotherapy
  9. Mesenchymal Stromal Cells Increase the Natural Killer Resistance of Circulating Tumor Cells via Intercellular Signaling of cGAS‐STING‐IFNβ‐HLA
    Yi Ye, Guihui Qin, Hongmei Yang, Jia Hao, Qibing Zeng, Dejin Zheng, Sen Ye, Zhiming Zhang, Tzu‐Ming Liu, Kathy Qian Luo et al. · 2024 · Advanced Science
  10. Targeting STING signaling for the optimal cancer immunotherapy
    Yan Xu, Ying Xiong · 2024 · Frontiers in Immunology
  11. STING-Dependent Interferon-λ1 Induction in HT29 Cells, a Human Colorectal Cancer Cell Line, After Gamma-Radiation
    Jianzhou Chen, Boštjan Markelc, Jakob Kaeppler, Vivian M.L. Ogundipe, Yunhong Cao, William Gillies McKenna, Ruth J. Muschel · 2018 · International Journal of Radiation Oncology*Biology*Physics
  12. Head and Neck Cancer Immunotherapy beyond the Checkpoint Blockade
    Blake R. Heath, Nicole Lynn Michmerhuizen, Christopher R. Donnelly, Kanokwan Sansanaphongpricha, Duxin Sun, John Chad Brenner, Yu L. Lei · 2019 · Journal of Dental Research
  13. The activation of cGAS-STING pathway offers novel therapeutic opportunities in cancers
    Yumin Wang, Yonglin Zhu, Yuwei Cao, Yulin Li, Zhe Zhang, Joshua S. Fleishman, Sihang Cheng, Jichao Chen, Mingchao Ding · 2025 · Frontiers in Immunology
  14. Midostaurin Modulates Tumor Microenvironment and Enhances Efficacy of Anti-PD-1 against Colon Cancer
    Cheng-Ta Lai, Chih‐Wen Chi, Shu-Hua Wu, Hui-Ru Shieh, Jiin‐Cherng Yen, Yu-Jen Chen · 2022 · Cancers
  15. A recombinant oncolytic influenza virus expressing a PD-L1 antibody induces CD8+ T-cell activation via the cGas-STING pathway in mice with hepatocellular carcinoma
    Fang Sun, Yan Xu, Zhuoya Deng, Penghui Yang · 2023 · International Immunopharmacology
  16. STING Activation and its Application in Immuno-Oncology
    Yiqian Lian, Kevin J. Duffy, Jingsong Yang · 2019 · Current Topics in Medicinal Chemistry
  17. Downregulation of cGAS/STING expression in tumor cells by cancer-associated fibroblasts in colorectal cancer
    Ryo Kanoda, Shotaro Nakajima, Hirokazu Okayama, Akinao Kaneta, Shun Chida, Takuro Matsumoto, Katsuharu Saito, Tomohiro Kikuchi, Yuya Maruyama, Hiroya Suzuki et al. · 2025 · Scientific Reports
  18. 2′,3′‐Cyclic GMP‐AMP Dinucleotides for STING‐Mediated Immune Modulation: Principles, Immunotherapeutic Potential, and Synthesis
    Mengdi Shang, Kuan Lu, Wenli Guan, Shujie Cao, Mengtian Ren, Chuanzheng Zhou · 2021 · ChemMedChem
  19. Agents of cancer immunosurveillance: HSPs and dsDNA
    Devanshi A. Nayak, Robert Julian Binder · 2022 · Trends in Immunology
  20. Activation of cGAS-STING Pathway Is Associated with MSI-H Stage IV Colorectal Cancer
    Nenad Kunac, Marina Degoricija, Jelena Viculin, Jasminka Omerović, Janoš Terzić, Katarina Vilović, Jelena Korać-Prlić · 2022 · Cancers
  21. Pharmacological boosting of cGAS activation sensitizes chemotherapy by enhancing antitumor immunity
    Haipeng Liu, Hang Su, Fei Wang, Yifang Dang, Yijiu Ren, Shenyi Yin, Huinan Lu, Hang Zhang, Jun Wu, Zhu Xu et al. · 2023 · Cell Reports
  22. Combination of IFN-gamma with STING agonist and PD-1 immune checkpoint blockade: a potential immunotherapy for gastric cancer
    Shahnaz Hosseinzadeh, Mahsa Imani, Farhad Pourfarzi, Narjes Jafari, Saeid Abediankenari, Elham Safarzadeh · 2024 · Medical Oncology
  23. STING mediates LPS-induced acute lung injury by regulating ferroptosis
    Yanli Gu, Liting Lv, Jiajia Jin, Xin Hua, Qiuli Xu, Ranpu Wu, Suhua Zhu, Xin Liu, Tangfeng Lv, Yong Song et al. · 2024 · Experimental Cell Research
  24. Opposing regulation of the STING pathway in hepatic stellate cells by NBR1 and p62 determines the progression of hepatocellular carcinoma
    Sadaaki Nishimura, Juan F. Linares, Antoine L’Hermitte, Ángeles Durán, Tania Cid-Diaz, Anxo Martínez-Ordóñez, Marc Ruíz-Martínez, Yotaro Kudo, Antonio Marzio, Mathias F Heikenwälder et al. · 2024 · Molecular Cell
  25. A STING-related prognostic score predicts high-risk patients of colorectal cancer and provides insights into immunotherapy
    Si-Yuan Chen, Siyu Chen, Wanjing Feng, Ziteng Li, Yixiao Luo, Xiaodong Zhu · 2021 · Annals of Translational Medicine
  26. Sensitizing immune unresponsive colorectal cancers to immune checkpoint inhibitors through MAVS overexpression
    Bin-Jin Hwang, Li-Chung Tsao, Chaitanya R. Acharya, Timothy N. Trotter, Pankaj Agarwal, Jun-Ping Wei, Tao Wang, Xiaoyi Yang, Gangjun Lei, Takuya Osada et al. · 2022 · Journal for ImmunoTherapy of Cancer
  27. Nanoscale Hafnium Metal–Organic Frameworks Enhance Radiotherapeutic Effects by Upregulation of Type I Interferon and TLR7 Expression
    Eun-Seo Choi, Madeleine R. Landry, Nathan D. Pennock, Megan J. Neufeld, Katherine Weinfurter, A.M. Goforth, Joshua M. Walker, Conroy Sun · 2023 · Advanced Healthcare Materials
  28. Analysis of mRNA-miRNA-lncRNA differential expression in prediabetes/type 2 diabetes mellitus patients as potential players in insulin resistance
    Hebatalla Said Ali, Marwa Mostafa Kamel, Sara H. A. Agwa, Mohamed S. Abdel-Hakeem, Mahmoud El‐Meteini, Marwa Matboli · 2023 · Frontiers in Endocrinology
  29. Exogenous DNA enhances DUOX2 expression and function in human pancreatic cancer cells by activating the cGAS-STING signaling pathway
    Stephen L. Wang, Yongzhong Wu, Mariam M. Konaté, Jiamo Lu, David J. Mallick, Smitha Antony, Jennifer L. Meitzler, Guojian Jiang, Iris M. Dahan, Agnes N. Juhasz et al. · 2023 · Free Radical Biology and Medicine
  30. Synergistic combination of oncolytic virotherapy with CAR T-cell therapy
    Adam Ajina, John F. Maher · 2019 · Progress in molecular biology and translational science
  31. Mitochondria as the decision makers for cancer cell fate: from signaling pathways to therapeutic strategies
    Ilaria Genovese, Bianca Vezzani, Alberto Danese, Lorenzo Modesti, Veronica Angela Maria Vitto, Virginia Corazzi, Stefano Pelucchi, Paolo Pinton, Carlotta Giorgi · 2020 · Cell Calcium
  32. Antigen-presenting cell activation requires intrinsic and extrinsic STING signaling after the phagocytosis of DNA-damaged cells
    Seongji Park, Jeonghyun Ahn, Glen N. Barber · 2024 · Science Immunology
  33. The role of type I interferon signaling in myeloid anti-tumor immunity
    Sofie Patrizia Meyer, Rebekka Bauer, Bernhard Brüne, Tobias Schmid · 2025 · Frontiers in Immunology
  34. Targeting Neoepitopes to Treat Solid Malignancies: Immunosurgery
    Eric de Sousa, Joana R. Lérias, Antonio Lopez-beltran B, Georgia Paraschoudi, Carolina Condeço, Jéssica Kamiki, Patrícia António, Nuno Figueiredo, Carlos Torres Carvalho, Mireia Castillo-Martín et al. · 2021 · Frontiers in Immunology
  35. Histone Deacetylase 3 Governs β-Estradiol-ERα-Involved Endometrial Tumorigenesis via Inhibition of STING Transcription
    Guofang Chen, Qiang Yan, Lin Liu, Xinyue Wen, Hongliang Zeng, Shasha Yin · 2022 · Cancers
  36. STAT2 hinders STING intracellular trafficking and reshapes its activation in response to DNA damage
    Chenyao Wang, Nan Jing, Elise G. Holvey-Bates, Xing Chen, Samantha M. Wightman, Muhammad-Bilal Latif, Junjie Zhao, Xiaoxia Li, Ganes C. Sen, George Robert Stark et al. · 2023 · Proceedings of the National Academy of Sciences
  37. Activation of STING in Response to Partial-Tumor Radiation Exposure
    Mickael Mathieu, Sadna Budhu, Prerna Ramesh Nepali, James Russell, Simon N. Powell, John Laurence Humm, Joseph O. Deasy, Adriana Haimovitz‐Friedman · 2023 · International Journal of Radiation Oncology*Biology*Physics
  38. The Role of the Toll-like Receptor 2 and the cGAS-STING Pathways in Breast Cancer: Friends or Foes?
    Chiara Cossu, Antonino Di Lorenzo, Irene Fiorilla, Alberto Maria Todesco, Valentina Audrito, Laura Conti · 2023 · International Journal of Molecular Sciences
  39. Stimulating STING for cancer therapy: Taking the extracellular route
    Lingyin Li · 2024 · Cell chemical biology
  40. Colorectal cancer-specific IFNβ delivery overcomes dysfunctional dsRNA-mediated type I interferon signaling to increase the abscopal effect of radiotherapy
    Kevin Chih‐Yang Huang, Shu‐Fen Chiang, Hsin‐Yu Chang, Wei-Ze Hong, Jhen-Yu Chen, Pei‐Chih Lee, Ji‐An Liang, Tao‐Wei Ke, Shin‐Lei Peng, An‐Cheng Shiau et al. · 2024 · Journal for ImmunoTherapy of Cancer
  41. Antagonistic roles of cGAS/STING signaling in colorectal cancer chemotherapy
    Beiyuan Liang, Xuanxuan Xing, Hayden Storts, Zhen Ye, Hazel Claybon, Ryan Austin, Rachel Ding, Bei Liu, Haitao Wen, Wayne O. Miles et al. · 2024 · Frontiers in Oncology
  42. Overcoming malignant cell-based mechanisms of resistance to immune checkpoint blockade antibodies
    Reham Ajina, David J. Zahavi, Yongwei Zhang, Louis M. Weiner · 2019 · Seminars in Cancer Biology
  43. The apoptosome molecular timer synergises with XIAP to suppress apoptosis execution and contributes to prognosticating survival in colorectal cancer
    Gavin Fullstone, Tabea L. Bauer, Cristiano Guttà, Manuela Salvucci, Jochen H.M. Prehn, Markus Rehm · 2020 · Cell Death and Differentiation
  44. STING differentially regulates experimental GVHD mediated by CD8 versus CD4 T cell subsets
    Cameron S. Bader, Henry Barreras, Casey O. Lightbourn, Sabrina N. Copsel, Dietlinde Wolf, Jingjing Meng, Jeonghyun Ahn, Krishna V. Komanduri, Bruce R. Blazar, Lei Jin et al. · 2020 · Science Translational Medicine
  45. Combining Oncolytic Viruses and Small Molecule Therapeutics: Mutual Benefits
    Bart Spiesschaert, Katharina Angerer, John Park, Guido Wollmann · 2021 · Cancers
  46. DNA methylation protects cancer cells against senescence
    Chen, Xiaoying, Yamaguchi, Kosuke, Rodgers, Brianna, Goehrig, Delphine, Vindrieux, David, Lahaye, Xavier, Nolot, Matthieu, Ferry, Laure, Lanciano, Sophie, Martin, Nadine et al. · 2025 · Nature Communications
  47. In Situ Vaccination by Tumor Ablation: Principles and Prospects for Systemic Antitumor Immunity
    Tinatin Chikovani, Eli Magen · 2025 · Vaccines
  48. Prognostic Perspectives of STING and PD-L1 Expression and Correlation with the Prognosis of Epstein-Barr Virus-Associated Gastric Cancers
    Qi Sun, Yao Shi Fu, Xiaobing Chen, Lin Li, Hongyan Wu, Yixuan Liu, Haojun Xu, Guoren Zhou, Xiangshan Fan, Hongping Xia · 2022 · Gut and Liver
  49. The role of dendritic cells in radiation-induced immune responses
    Aanchal Preet Kaur, Alejandro F. Alice, Marka R. Crittenden, Michael J. Gough · 2023 · International review of cytology
  50. Nucleic Acid Sensing and Innate Immunity: Signaling Pathways Controlling Viral Pathogenesis and Autoimmunity
    Laura R. H. Ahlers, Alan G. Goodman · 2016 · Current Clinical Microbiology Reports
  51. A STING inhibitor suppresses EBV‐induced B cell transformation and lymphomagenesis
    Shouhei Miyagi, Takahiro Watanabe, Yuya Hara, Masataka Arata, Md. Kamal Uddin, Keisuke Mantoku, Ken Sago, Yusuke Yanagi, Takeshi Suzuki, H. M. Abdullah Al Masud et al. · 2021 · Cancer Science
  52. The cGAS-STING signaling pathway is modulated by urolithin A
    Helena Borland Madsen, Jae Hyeon Park, X. Chu, Yujun Hou, Zaiwang Li, Lene Juel Rasmussen, Deborah L. Croteau, Vilhelm A. Bohr, Mansour Akbari · 2023 · Mechanisms of Ageing and Development
  53. Radiotherapy enhances anticancer CD8 T cell responses by cGAMP transfer through LRRC8A/C volume-regulated anion channels
    Limin Cao, Wang Li, Zhihong Li, Xia Wei, Jinqiu Ding, Chun Zhou, Xia Chen, Zhicheng Huang, Zhugui Shao, Junchen Shen et al. · 2025 · Science Immunology
  54. Pathophysiological Role of Nucleic Acid-Sensing Pattern Recognition Receptors in Inflammatory Diseases
    Norisuke Kano, Guang Han Ong, Daisuke Ori, Taro Kawai · 2022 · Frontiers in Cellular and Infection Microbiology
  55. Immune checkpoint inhibition improves antimyeloma activity of bortezomib and STING agonist combination in Vk*MYC preclinical model
    Olga Sokołowska, Anna Rodziewicz-Lurzyńska, Zofia Pilch, Hanna Kędzierska, Justyna Chlebowska, Anna Sosnowska, Anna Szumera‐Ciećkiewicz, Kamil Sokół, Joanna Barankiewicz, Aleksander Salomon‐Perzyński et al. · 2022 · Clinical and Experimental Medicine
  56. cGAS-STING pathway targeted therapies and their applications in the treatment of high-grade glioma
    Shashwat Tripathi, Hinda Najem, Akanksha Mahajan, Peng Zhang, Justin Low, Alexander H. Stegh, Michael A. Curran, David M. Ashley, Charles David James, Amy B. Heimberger · 2022 · F1000Research
  57. Effect of stimulator of interferon genes (STING) signaling on radiation-induced chemokine expression in human osteosarcoma cells
    Sita S. Withers, Cambri E. Moeller, Cally N. Quick, Chin‐Chi Liu, Shelby M. Baham, Jayme Looper, Ramesh Subramanian, Konstantin Gus Kousoulas · 2023 · PLoS ONE
  58. Genetic and immune landscape evolution in MMR‐ deficient colorectal cancer
    Benjamin R. Challoner, Andrew Woolston, David K. Lau, Marta Buzzetti, Caroline Fong, Louise J. Barber, Gayathri Anandappa, Richard Crux, Ioannis Assiotis, Kerry Fenwick et al. · 2023 · The Journal of Pathology
  59. ATP-elicited Cation Fluxes Promote Volume-regulated Anion Channel LRRC8/VRAC Transport cGAMP for Antitumor Immunity
    Li Wang, Limin Cao, Zhihong Li, Zhugui Shao, Xia Chen, Zhicheng Huang, Xiaoxiao He, Junke Zheng, L.-Z. Liu, Xin‐Ming Jia et al. · 2024 · The Journal of Immunology
  60. Loss of the DNA repair protein, polynucleotide kinase/phosphatase, activates the type 1 interferon response independent of ionizing radiation
    Wisdom Deebeke Kate, Mesfin Fanta, Michael Weinfeld · 2024 · Nucleic Acids Research
  61. Micronuclei: origins, assays, mechanisms, diseases and treatments
    Hailong Duan, Xin Peng, Sha Qin, Yanmin Zhou, Desheng Xiao, Yongguang Tao, Shuang Liu · 2026 · Signal Transduction and Targeted Therapy
  62. Protocol to induce and assess cGAS-STING pathway activation in vitro
    Hanane Chamma, Soumyabrata Guha, Nadine Laguette, Isabelle K. Vila · 2022 · STAR Protocols
  63. Role of STING protein in breast cancer: mechanisms and therapeutic implications
    Yue Jiang, Juliang Zhang · 2022 · Medical Oncology
  64. Intrinsic features of the cancer cell as drivers of immune checkpoint blockade response and refractoriness
    Chiara Ursino, Cécile Mouric, Laurent Gros, Nathalie Bonnefoy, Julien Faget · 2023 · Frontiers in Immunology
  65. High levels of tumor cell-intrinsic STING signaling are associated with increased infiltration of CD8+ T cells in dMMR/MSI-H gastric cancer
    Ryo Kanoda, Shotaro Nakajima, Satoshi Fukai, Motonobu Saito, Katsuharu Saito, Hiroya Suzuki, Tomohiro Kikuchi, Azuma Nirei, Hirokazu Okayama, Kosaku Mimura et al. · 2024 · Scientific Reports
  66. Involvement of GATA1 and Sp3 in the activation of the murine STING gene promoter in NIH3T3 cells
    Yanyan Xu, Rui Jin, Guo‐Ping Zhou, Hua‐Guo Xu · 2017 · Scientific Reports
  67. Mathematical modeling of the cGAS pathway reveals robustness of DNA sensing to TREX1 feedback
    Robert W. Gregg, Saumendra N. Sarkar, Jason E. Shoemaker · 2018 · Journal of Theoretical Biology
  68. Role of Base Excision Repair in Innate Immune Cells and Its Relevance for Cancer Therapy
    Shengyuan Zhao, Samy L. Habib, Alireza Ghodsi Senejani, Manu M. Sebastian, Dawit Kidane · 2022 · Biomedicines
  69. The multifaceted role of micronuclei in tumour progression: A whole organism perspective.
    Molly A Guscott, Akash Saha, Jovanna Maharaj, Sarah Elizabeth McClelland · 2022 · The International Journal of Biochemistry & Cell Biology
  70. The cGAS-STING axis: a comprehensive review from immune defense to disease pathogenesis
    Ashita Sood · 2025 · Immunologic Research
  71. GALNT6 dual regulates innate immunity STING signaling and PD-L1 expression to promote immune evasion in pancreatic ductal adenocarcinoma
    Suli Chong, Yang Liu, Ziming Bian, Dongxue Hu, Shiqun Guo, Chenfei Dong, Jiayue Zeng, Sairong Fan, Xiaoming Chen · 2025 · Cellular Signalling
  72. Cell-type specific activation of the cGAS-STING pathway in tumor immunotherapy: mechanisms and therapeutic implications
    Lusheng Wang, Sudi Zhu, Zhixian Ding, Jie Hong, Lijie Zheng, Jiting Sun, Yu Tang, Xiaohui Chen, Xiang Yong, Mengxue Hu et al. · 2026 · Journal of Translational Medicine
  73. Mitotic SENP3 activation couples with cGAS signaling in tumor cells to stimulate anti-tumor immunity
    Gaolei Hu, Yalan Chen, Xinyu Yang, Yang Wang, Jianli He, Tianshi Wang, Qiuju Fan, Liufu Deng, Jun Tu, Hongsheng Tan et al. · 2022 · Cell Death and Disease
  74. Alternative pathways driven by STING: From innate immunity to lipid metabolism
    Isabelle K. Vila, Soumyabrata Guha, Joanna Maria Kalucka, David P. Olagnier, Nadine Laguette · 2022 · Cytokine & Growth Factor Reviews
  75. Tracing the STING exocytosis pathway during herpes viruses infection
    Christos Dogrammatzis, Rabina Saud, Hope Waisner, Sarah Lasnier, Sreenath Muraleedharan Suma, Brandon Grieshaber, Maria Kalamvoki · 2024 · mBio
  76. Activation of STING by the novel liposomal TLC388 enhances the therapeutic response to anti-PD-1 antibodies in combination with radiotherapy
    Jhen-Yu Chen, Po-Yu Lin, Wei-Ze Hong, Pei-Chen Yang, Shu‐Fen Chiang, Hsin-Yu Chang, Tao‐Wei Ke, Ji‐An Liang, William Tzu‐Liang Chen, K. S. Clifford Chao et al. · 2024 · Cancer Immunology Immunotherapy
  77. Stimulator of Interferon Genes Protein (STING) Expression in Cancer Cells: A Tissue Microarray Study Evaluating More than 18,000 Tumors from 139 Different Tumor Entities
    Anne Menz, Julia Zerneke, Florian Viehweger, Şeyma Büyücek, David Dum, Ria Schlichter, Andrea Hinsch, Ahmed Abdulwahab Bawahab, Christoph Fraune, Christian Bernreuther et al. · 2024 · Cancers
  78. Combined treatment of small cell lung cancer using radiotherapy and immunotherapy: Challenges and updates
    Zhumin Cao, Kai Deng, Jinxiu Jiang, Ke Tian, Bin Wang · 2024 · Biomedicine & Pharmacotherapy
  79. Extracellular vesicles as missiles for enhanced anti-tumor efficacy of oncolytic viruses: from disseminating oncolysis and anti-tumor immunity to targeted delivery
    Mehrnoush Safarzadeh, Nastaran Saadat, Sara Abbasi-Molaei, Mohsen Rastegari‐Pouyani · 2025 · Cell Communication and Signaling
  80. STING Restricts oHSV Replication and Spread in Resistant MPNSTs but Is Dispensable for Basal IFN-Stimulated Gene Upregulation
    Joel M. Lee, Mohammed G. Ghonime, Kevin A. Cassady · 2019 · Molecular Therapy — Oncolytics
  81. CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX
    Jack T. Whelan, Ragunath Singaravelu, Fuan Wang, Adrian Pelin, Levi A. Tamming, Giuseppe Pugliese, Nikolas Tim Martin, Mathieu J. F. Crupi, Julia Petryk, Bradley Austin et al. · 2023 · Frontiers in Immunology
  82. DNA damage in protective and adverse inflammatory responses: Friend of foe?
    Tetiana Poliezhaieva, Maria Ermolaeva · 2016 · Mechanisms of Ageing and Development
  83. Immunotherapy Sensitivity of Mismatch Repair-Deficient Cancer: Mutation Load Is Not Enough
    Marco Gerlinger · 2021 · Cancer Cell
  84. Precision targeting of STING: Challenges, innovations, and clinical outlook for cancer therapy
    Jiaqi Shi, Yingying Zhang, Na Zhao, Ekihiro Seki, Li Ma, Gordana M. Kocic, Xiaobo Li, Janoš Terzić, Tongsen Zheng · 2025 · The Innovation
  85. Advances in nanomaterials for enhancing cGAS-STING pathway mediated anti-tumor treatment
    Ruicheng Wu, Jie Wang, Dengxiong Li, Ao Li, Koo Han Yoo, Zhihong Liu, Wuran Wei, Zhipeng Wang, Dechao Feng · 2025 · Materials Today Bio
  86. Ferroptosis and the cGAS–STING pathway into precision nano-immuno-theranostics: A mechanistic paradigm for reversing drug resistance in hepatocellular carcinoma
    Alaa Elmetwalli · 2025 · Drug Resistance Updates
  87. The cGAS-STING pathway in cancer: friend or foe
    Qian Li, Qingkang Song, Lingli Ma, Kuan Kang, Xiaoru Zhu, Yuan Li, Xin Lin, Xingxing Lu, Zhaoyang Zeng, Guiyuan Li et al. · 2026 · Cell Death and Disease
  88. A High Immune-Related Index with the Suppression of cGAS-STING Pathway is a Key Determinant to Herceptin Resistance in HER2+ Breast Cancer
    Ruizhao Cai, Qingshan Chen, Dechang Zhao, Yan Wang, Ling Zhou, Kaiming Zhang, Jialu Shan, Zhiling Li, Yuhong Chen, Hailiang Zhang et al. · 2024 · International Journal of Biological Sciences
  89. Oncolytic HSV: Underpinnings of Tumor Susceptibility
    Chase Kangas, Eric Krawczyk, Bin He · 2021 · Viruses
  90. Voices from beyond the grave: The impact of apoptosis on the microenvironment
    Joel S. Riley, Florian J. Bock · 2022 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  91. STING pathway expression in low‐grade serous carcinoma of the ovary: an unexpected therapeutic opportunity?
    Jutta K. Huvila, Dawn R. Cochrane, Monica Ta, Christine Chow, Kendall Greening, Samuel C. Y. Leung, Anthony Nicholas Karnezis, Analisa V. DiFeo, David D. Huntsman · 2021 · The Journal of Pathology Clinical Research
  92. PPT1 is a negative regulator of STING signaling in cancer cells and its inhibition reactivates immune surveillance in cold tumors
    Shreya R. Chowdhury, Chaitanya Naimesh Parikh, Arshia N. Kaur, Kelly D. DeMarco, Hadiya K. Giwa, Alok Mishra, Katherine C. Murphy, Lin Zhou, Boyang Ma, Tianyi Ye et al. · 2025 · Proceedings of the National Academy of Sciences
  93. Advances in immunotherapy for colorectal cancer: overcoming resistance in mismatch repair-proficient tumors
    Mohammad Reza Keivany, Elham Shojaei Asrami, Mohammadreza Besharatloo, Hanieh Latifi, Amir Hossein Barjasteh · 2026 · Cancer Cell International
  94. The cGAS/STING signaling pathway: a cross-talk of infection, senescence and tumors
    Peng-Hui Zeng, Wen-Jun Yin · 2022 · Cell Cycle
  95. T-Cell Mediated Immunity in Merkel Cell Carcinoma
    Kelsey Ouyang, David X. Zheng, George W. Agak · 2022 · Cancers
  96. The Impact of Tumor Cell-Intrinsic Expression of Cyclic GMP-AMP Synthase (cGAS)-Stimulator of Interferon Genes (STING) on the Infiltration of CD8+ T Cells and Clinical Outcomes in Mismatch Repair Proficient/Microsatellite Stable Colorectal Cancer
    Shotaro Nakajima, Akinao Kaneta, Hirokazu Okayama, Katsuharu Saito, Tomohiro Kikuchi, Eisei Endo, Takuro Matsumoto, Satoshi Fukai, Mei Sakuma, Takahiro Sato et al. · 2023 · Cancers
  97. Sulfonated Perylene as Three‐in‐One STING Agonist for Cancer Chemo‐Immunotherapy
    Xue‐Jie Zhao, Rijie Zheng, Bianbian Zhang, Ying Zhao, Wanli Xue, Yingfei Fang, Yongwei Huang, Meizhen Yin · 2024 · Angewandte Chemie
  98. Riluzole Enhancing Anti-PD-1 Efficacy by Activating cGAS/STING Signaling in Colorectal Cancer
    Beiyuan Liang, Misbah Khan, Hayden Storts, Evan H. Zhang, Xinru Zheng, Xuanxuan Xing, Hazel Claybon, Jenna L. Wilson, Chunjie Li, Ning Yi Jin et al. · 2024 · Molecular Cancer Therapeutics
  99. Therapeutic targeting of cGAS–STING pathway in lung cancer
    Jinli Wang, Lumin Xing · 2024 · Cell Biology International
  100. Research progress and development potential of oncolytic vaccinia virus
    Xinyu Zhang, Jiangshan He, Yiming Shao · 2025 · Chinese Medical Journal